Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 29 (BNIP3P29)

Target
BNIP3P29
Molecular classification
Other (Pseudogene)
01

Overview

BCL2 interacting protein 3 pseudogene 29 (BNIP3P29) is a non-functional remnant of the BNIP3 gene located in the human genome. Annotated as a pseudogene, it does not encode a functional protein but stems from the BCL2-interacting protein family involved in apoptosis and cell death pathways[2][7]. No evidence supports therapeutic targeting, biological function, or disease association for BNIP3P29 itself. The functional protein *BNIP3* (encoded by another locus) participates in mitochondrial regulation, autophagy, and cell death, and is implicated in cancer biology[1], but BNIP3P29 does not share these attributes[2][7]. Key distinction: BNIP3P29 should not be confused with BNIP3 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3), which is a functional protein involved in cell death and survival[1]. BNIP3P29 is solely a pseudogene and not a therapeutic target or biomolecule with known function.

Other names
BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 29BNIP3P29

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 29 (BNIP3P29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 29 (BNIP3P29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call